0.00
price down icon100.00%   -1.82
 
loading
Precedente Chiudi:
$1.82
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$182.47M
Reddito:
$47.04M
Utile/perdita netta:
$-63.98M
Rapporto P/E:
0.00
EPS:
-0.8064
Flusso di cassa netto:
$-34.39M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
Value
$0.00
$0.00
Intervallo di 1 settimana:
Value
$0.00
$1.92
Portata 52W:
Value
$0.00
$3.5107

Innate Pharma Adr Stock (IPHA) Company Profile

Name
Nome
Innate Pharma Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
177
Name
Cinguettio
@InnatePharma
Name
Prossima data di guadagno
2024-09-12
Name
Ultimi documenti SEC
Name
IPHA's Discussions on Twitter

Confronta IPHA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IPHA
Innate Pharma Adr
0.00 182.47M 47.04M -63.98M -34.39M -0.8064
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Innate Pharma Adr Stock (IPHA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-09-03 Aggiornamento SVB Leerink Mkt Perform → Outperform
2020-12-15 Downgrade SVB Leerink Outperform → Mkt Perform
2020-11-24 Iniziato Goldman Neutral

Innate Pharma Adr Borsa (IPHA) Ultime notizie

pulisher
May 28, 2025

Why Kingsoft Cloud Holdings Stock Plummeted by Nearly 8% Today - The Globe and Mail

May 28, 2025
pulisher
May 13, 2025

Earnings call transcript: Innate Pharma Q1 2025 earnings reveal strategic focus By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Innate Pharma Q1 2025 earnings reveal strategic focus - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Innate Pharma Q1 2025 slides: pipeline advances and Sanofi partnership strengthen outlook - Investing.com

May 13, 2025
pulisher
May 13, 2025

Innate Pharma Q1 2025 slides: pipeline advances and Sanofi partnership strengthen outlook By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
Apr 30, 2025

Innate Pharma reports promising preclinical results for cancer drug IPH4502 By Investing.com - Investing.com India

Apr 30, 2025
pulisher
Apr 29, 2025

Innate Pharma stock surges on promising preclinical data By Investing.com - Investing.com South Africa

Apr 29, 2025
pulisher
Apr 29, 2025

Innate Pharma reports promising preclinical results for cancer drug IPH4502 - Investing.com

Apr 29, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains $11 target on Innate Pharma stock By Investing.com - Investing.com South Africa

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains $11 target on Innate Pharma stock - Investing.com

Apr 24, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy rating on Innate Pharma stock By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy rating on Innate Pharma stock - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Innate Pharma Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Innate Pharma Q4 2024 sees strategic advances By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Innate Pharma Q4 2024 sees strategic advances - Investing.com

Mar 27, 2025
pulisher
Jan 17, 2025

Innate Pharma shares retain Buy rating on long-term strategy - Investing.com

Jan 17, 2025
pulisher
Dec 23, 2024

AZN Stock Price and Chart — LSE:AZN - TradingView

Dec 23, 2024
pulisher
Aug 06, 2024

Contrast Security Introduces Application Detection and Response (ADR) to Identify and Block Attacks and Zero Days on Applications in Production - Business Wire

Aug 06, 2024
pulisher
Jun 10, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

Jun 10, 2024
pulisher
Mar 31, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 31, 2024
pulisher
Jan 04, 2024

Innate Pharma (IPHA) Gains as FDA Lifts Hold on Lymphoma Study - Zacks Investment Research

Jan 04, 2024
pulisher
Dec 12, 2022

Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286 - Business Wire

Dec 12, 2022
pulisher
Apr 29, 2022

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins - Equities.com

Apr 29, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Nov 01, 2019

Innate Pharma (IPHA) Stock Price, News & Analysis - MarketBeat

Nov 01, 2019

Innate Pharma Adr Azioni (IPHA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):